SCHEMBL7691968

SCHEMBL7691968

O=C(NCc1cccc(F)c1)C1CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 4/20 0.48
KMT2A Q03164 1/20 0.48
RAB9A P51151 3/20 0.47
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MTOR P42345 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.43
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
CCNT1 O60563 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691966 1.00 SMN1; SMN2 (0.52) SMN1; SMN2NPC1KMT2ARAB9APOLB
SCHEMBL7693632 0.89 SMN1; SMN2 (0.55) SMN1; SMN2NPC1KMT2ARAB9APOLB
SCHEMBL7693636 0.89 SMN1; SMN2 (0.55) SMN1; SMN2NPC1KMT2ARAB9APOLB
SCHEMBL7085647 0.89 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7089468 0.89 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7085654 0.89 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7696283 0.89 MAPT (0.54) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7694028 0.89 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7694033 0.89 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7698815 0.89 MAPT (0.54) SMN1; SMN2NPC1RAB9APOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed